Stockscreener 앱 받기
12.32
3.16%
-0.34
시간 외 거래:
12.50
0.18
+1.46%
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - GlobeNewswire Inc.
Is the Options Market Predicting a Spike in Integra LifeSciences Stock? - Yahoo Finance
3 Reasons to Sell IART and 1 Stock to Buy Instead - Yahoo Finance
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by BNP Paribas Financial Markets - Defense World
Bank of America Corp DE Has $13.42 Million Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Recommendation of “Reduce” from Analysts - Defense World
Northern Trust Corp Acquires 80,090 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences expands equity incentive plan By Investing.com - Investing.com Canada
Integra LifeSciences expands equity incentive plan - Investing.com
JMP Securities Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Integra Lifesciences (IART): Analyst Lowers Price Target to $25 | IART Stock News - GuruFocus
Integra LifeSciences stock target cut to $25 by JMP - Investing.com South Africa
Integra LifeSciences (IART) Sees Lowered Price Target Amid Marke - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price - Defense World
U.S. Regenerative Artificial Skin Market 2025-2032: Top Trends - openPR.com
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings - Defense World
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Rev - GuruFocus
Integra LifeSciences (IART) Faces Adjusted Price Target Amid Revenue Concerns | IART Stock News - GuruFocus
Stock Hits Across The Board As Companies Adjust Expectations - Finimize
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) - GuruFocus
JP Morgan Adjusts Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Wells Fargo Lowers Price Target for Integra Lifesciences (IART) | IART Stock News - GuruFocus
Integra LifeSciences Holdings First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut - Nasdaq
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript - Insider Monkey
Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Inv - GlobeNewswire
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | I - GuruFocus
Wells Fargo Adjusts Integra LifeSciences (IART) Price Target | IART Stock News - GuruFocus
Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Q1 2025 Earnings Call - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategi - GuruFocus
Integra: Q1 Earnings Snapshot - MySA
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Bea - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Rev - GuruFocus
Integra LifeSciences (IART) Reports Q1 Revenue Surpassing Expectations | IART Stock News - GuruFocus
Integra LifeSciences (IART) Reports Q1 2025 Results and Strategic Moves - GuruFocus
Why Integra LifeSciences (IART) Shares Are Getting Obliterated Today - Yahoo Finance
Integra LifeSciences Q1 2025 Earnings Call Transcript - MarketBeat
Long-Term Shareholders Have Rights – If You Hold Akero - GlobeNewswire
Long-Term Shareholders Have Rights – If You Hold Akero Therapeutics, Inc. (NASDAQ: AKRO); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Mercury Systems, Inc. (NASDAQ: MRCY); or Virtu Financial Inc. (NASDAQ: VIRT), Contact Grabar La - TradingView
Earnings call transcript: Integra LifeSciences misses Q1 2025 targets, stock plunges - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Integra LifeSciences misses Q1 estimates, shares fall 4% - Investing.com
Integra LifeSciences misses Q1 estimates, shares fall 4% By Investing.com - Investing.com Canada
Integra LifeSciences Slashes FY25 Adj. EPS OutlookUpdate - Nasdaq
Integra Lifesciences Q1 2025 Earnings: Adjusted EPS of $0.41 Beats Estimates, Revenue Hits $382.7 Million - GuruFocus
Integra LifeSciences (IART) Q1 Earnings: Misses EPS, Exceeds Revenue Expectations - GuruFocus
Integra LifeSciences Reports First Quarter 2025 Financial Results - TradingView
0.61%
0.76%
자본화:
|
볼륨(24시간):